Malaria

Malaria parasites stop eating to avoid artemisinin antimalarials

Dr Simon Cobbold, Dr Tuo Yang and Prof Leann Tilley, celebrating their discovery of the mechanism of artemisinin resistance, published in Cell Reports today.

Academia and industry join forces against malaria

Professor Leann Tilley and Dr Stanley Xie from the Bio21 Institute are working with experts from the Japanese company, Takeda Pharmaceuticals, and Swiss-based foundation, Medicines for Malaria Venture (MMV), in a double-pronged effort to develop new antimalarial drugs.  

CryoEM insights into the nanomachine that powers the cell’s garbage disposal system

Capitalising on the revolution brought about by structural cryo-electron microscopy (cryo-EM), a Bio21 team led by Dr Mike Griffin and Prof Leann Tilley has generated molecular movies of a sophisticated nano-machine, called the proteasome. 

Collective intelligence needed to solve malaria

Collective intelligence needed to solve malaria. Hear Leann Tilley explain

Bio21 Big Picture Seminar: Alternative Drug Discovery in Pharma...a snapshot of diversity in GSK drug discovery through collaboration

Friday, 26 August, 2016 - 13:15

Hear John Haselden, VP and Head of Malaria Discovery GSK speak about examples from GSK’s 'alternative' portfolio, including Diseases of the Developing World and Maternal/Neonatal Health.

Biochemistry and Molecular Biology Seminar Series presents Stephen Batinovic, PhD Oration

Wednesday, 6 April, 2016 - 12:00 to 13:00

“A network of protein interactions required for trafficking of PfEMP1 in P. falciparum infected erythrocytes” 

Biochemistry and Molecular Biology Seminar Series presents A/Prof Fasseli Coulibaly, Monash University

Wednesday, 23 March, 2016 - 12:00 to 13:00

"In vivo crystals of viruses: a challenge for structural biology, an opportunity for new vaccines" presented by Associate Professor Fasseli CoulibalyMonash University, Structural Virology Laboratory.

Biochemistry and Molecular Biology Seminar Series presents Dr Wai-Hong Tam, WEHI

Wednesday, 16 March, 2016 - 12:00 to 13:00

"Malaria Parasite Invasion: versatile structural scaffolds and alternate erythrocyte receptors"

Media Release: New hope in global race to beat malaria parasite’s deadly new resistance

Scientists have made a major breakthrough in the global search for a new drug to beat the malaria parasite’s growing resistance to first-defence treatments.

Academia and industry join forces against malaria

Professor Leann Tilley and Stanley Cheng Xie from the Bio21 Institute are joining with Takeda Pharmaceuticals in the fight against malarial drug resistance.

Pages

Subscribe to RSS - Malaria